CMV: current management and opportunities for future treatments for Cytomegalovirus
hemato-oncology, Syndicated Studies, CMV, Infectiology
New in 2023 !
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment...
Our range of syndicated studies now covers over 30 indications, many of them with results already...
How does COVID-19 affectthe HCPS relationships with patients and with the pharmaceutical industry?...
Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...
As the global number of infected cases surpasses 46 million (Nov 2, 2020), there is a non-stop...
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
When working on a new or existing brand within the DLBCL market it's important to have up to date...
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies
The DLBCL market is undergoing a period of change, and the relative performance of the various...
hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Following the release of our latest ebook, this is the first blog post in this series focusing on...
AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology
Introducing the latest eBook in AplusA's Hemato-Oncology series